{"log_id": 8462604880120237274, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.019238, "average": 0.90203, "min": 0.451532}, "location": {"width": 1044, "top": 297, "height": 64, "left": 326}, "words": "托伐他汀与克拉霉素必须合用的情况下,建议服用较低的阿托伐他汀维刊量a对于服用解"}, {"probability": {"variance": 0.02801, "average": 0.897584, "min": 0.502845}, "location": {"width": 553, "top": 349, "height": 50, "left": 322}, "words": "过4:剂量的患者:建议进行适当的临床检测"}, {"probability": {"variance": 0.022371, "average": 0.894942, "min": 0.393138}, "location": {"width": 1001, "top": 404, "height": 61, "left": 368}, "words": "伊曲康:阿托伐他汀20mg至40mg与伊曲康唑200g日合月可使阿托伐他汀的暴露"}, {"probability": {"variance": 0.011279, "average": 0.931304, "min": 0.515725}, "location": {"width": 1044, "top": 452, "height": 66, "left": 322}, "words": "增加1.5-2.3倍。在阿托伐他汀与伊曲康唑必须合用的情况下,建议求用较低的阿他汀"}, {"probability": {"variance": 0.018096, "average": 0.928267, "min": 0.422782}, "location": {"width": 811, "top": 507, "height": 54, "left": 320}, "words": "维持剂量对于服用超过40mg剂量的患者,建议进行适当的临庆监测"}, {"probability": {"variance": 0.019525, "average": 0.930613, "min": 0.447784}, "location": {"width": 989, "top": 560, "height": 61, "left": 370}, "words": "蛋白酶抑制判:蛋白扣制剂为已知的细胞色素P453A4抑制剂,与阿伐他汀合"}, {"probability": {"variance": 0.020404, "average": 0.897855, "min": 0.599676}, "location": {"width": 269, "top": 615, "height": 34, "left": 313}, "words": "月时,增其血装浓度"}, {"probability": {"variance": 0.008084, "average": 0.939734, "min": 0.605146}, "location": {"width": 992, "top": 667, "height": 57, "left": 370}, "words": "盐酸地尔卓:阿托伐他汀40ng与地尔硫卓240mg合用可使阿托伐他汀的暴露增加"}, {"probability": {"variance": 0.023045, "average": 0.927449, "min": 0.351392}, "location": {"width": 955, "top": 715, "height": 61, "left": 313}, "words": "51,在开始地尔硫卓治疗或其剂量调整后,建议对这些患进行适当的临床监测"}, {"probability": {"variance": 0.020779, "average": 0.927161, "min": 0.352863}, "location": {"width": 992, "top": 768, "height": 64, "left": 365}, "words": "依折姿布:单独使用依折麦布治疗与肌病的发生相关。因此依折麦布与阿伐他汀联会"}, {"probability": {"variance": 0.001935, "average": 0.981193, "min": 0.837954}, "location": {"width": 347, "top": 823, "height": 41, "left": 310}, "words": "使用时可能增加病的危险性"}, {"probability": {"variance": 0.012885, "average": 0.944218, "min": 0.420487}, "location": {"width": 996, "top": 873, "height": 61, "left": 361}, "words": "柚子汁:包含抑制细胞色素P4503A4的一种或更多成分,可增加经过该酶谢的药物"}, {"probability": {"variance": 0.027049, "average": 0.905219, "min": 0.454104}, "location": {"width": 1044, "top": 925, "height": 61, "left": 308}, "words": "浆浓度。入240ml轴子汁使阿托发他汀AIC增加37%,活性对羟基代谢物ATC降低"}, {"probability": {"variance": 0.020963, "average": 0.908715, "min": 0.412031}, "location": {"width": 1042, "top": 976, "height": 64, "left": 308}, "words": "2.4%:但是,入大量柚子汁(每天饮用超过1.2L,连续5天)增加阿托化他汀和活性(阿"}, {"probability": {"variance": 0.013288, "average": 0.93792, "min": 0.396949}, "location": {"width": 1042, "top": 1028, "height": 64, "left": 308}, "words": "托伐他汀和代谢物) IMG. COA还原酶排制剂AC分别为2.5倍和1.3倍。所以,建议服用"}, {"probability": {"variance": 0.038863, "average": 0.846362, "min": 0.456633}, "location": {"width": 450, "top": 1081, "height": 45, "left": 304}, "words": "阿托伐他汀者不应同时摄入大三柚子汁"}, {"probability": {"variance": 0.035802, "average": 0.860757, "min": 0.387102}, "location": {"width": 976, "top": 1134, "height": 61, "left": 354}, "words": "细胞色素P4503A4导剂:阿托他汀与细泡色索P45034导剂文:依非韦伦"}, {"probability": {"variance": 0.014832, "average": 0.934675, "min": 0.488476}, "location": {"width": 1044, "top": 1186, "height": 59, "left": 299}, "words": "利福平、贯叶连翘联合应用可以使阿托伐他汀血浆浓度产生不同水平的降低。由于利福平"}, {"probability": {"variance": 0.024868, "average": 0.920935, "min": 0.388167}, "location": {"width": 1044, "top": 1236, "height": 61, "left": 299}, "words": "的双作用机制导肝细胞细胞色素P4503A4和制细胞微取载体 OATPIBL)因为"}, {"probability": {"variance": 0.030124, "average": 0.908077, "min": 0.445656}, "location": {"width": 1079, "top": 1287, "height": 73, "left": 299}, "words": "在利福平给药后延迟阿托战他汀的药与阿托伐池汀血浆浓度的显著降低有关,因解配"}, {"probability": {"variance": 0.000826, "average": 0.985455, "min": 0.893553}, "location": {"width": 320, "top": 1342, "height": 41, "left": 297}, "words": "托伐他汀与利福平同时给药"}, {"probability": {"variance": 0.035016, "average": 0.865057, "min": 0.42683}, "location": {"width": 1069, "top": 1390, "height": 93, "left": 347}, "words": "维拉帕米和懒酮:尚末进行与维拉的米和供的药物相互作用研究拉帕米和"}, {"probability": {"variance": 0.03284, "average": 0.903929, "min": 0.359138}, "location": {"width": 1083, "top": 1435, "height": 68, "left": 292}, "words": "酮已知均可抑制CYPA4活性,与阿托伐们汀合用丁使托伐他汀的暴露增青限"}, {"probability": {"variance": 0.047034, "average": 0.899296, "min": 0.414452}, "location": {"width": 162, "top": 1520, "height": 34, "left": 345}, "words": "其他联治疗"}, {"probability": {"variance": 0.016688, "average": 0.8693, "min": 0.740117}, "location": {"width": 41, "top": 1522, "height": 29, "left": 1531}, "words": "24"}, {"probability": {"variance": 0.020548, "average": 0.921008, "min": 0.472101}, "location": {"width": 1049, "top": 1588, "height": 66, "left": 342}, "words": "吉非贝齐纤维衍生物:单独应用贝特类药物(如青非贝齐、孝扎贝特>有时房CEU"}, {"probability": {"variance": 0.031501, "average": 0.865423, "min": 0.378542}, "location": {"width": 1166, "top": 1634, "height": 105, "left": 288}, "words": "的发生有关到托伐他汀与纤维酸衍生物用,发生病的化险栏可能增(注意项史国潮"}, {"probability": {"variance": 0.03254, "average": 0.873018, "min": 0.426139}, "location": {"width": 640, "top": 1698, "height": 45, "left": 288}, "words": "与吉非以齐300g3合用可使阿托他汀的暴露增加24"}, {"probability": {"variance": 0.003625, "average": 0.955893, "min": 0.851858}, "location": {"width": 137, "top": 1728, "height": 41, "left": 1250}, "words": "有限公司"}, {"probability": {"variance": 0.014481, "average": 0.928366, "min": 0.486547}, "location": {"width": 989, "top": 1749, "height": 59, "left": 329}, "words": "地高辛:本品10ng与多个剂量的高辛联合用药时,地高辛的稳态血浆浓度不受影响"}, {"probability": {"variance": 0.016308, "average": 0.924276, "min": 0.42316}, "location": {"width": 1040, "top": 1799, "height": 64, "left": 283}, "words": "本品80mg日与地高辛联合用药时,地高辛浓度增加约205这是由于细泡膜转运蛋白P"}, {"probability": {"variance": 0.01228, "average": 0.925953, "min": 0.580232}, "location": {"width": 720, "top": 1851, "height": 52, "left": 283}, "words": "糖蛋白受到抑制。同对服用地高辛的患者应子以适当临未监测"}, {"probability": {"variance": 0.017868, "average": 0.918207, "min": 0.568864}, "location": {"width": 1001, "top": 1904, "height": 64, "left": 324}, "words": "口眼避孕药:本品与口服孕药合用时,烘诺酮和乙炔二醇的血浆液度增高。选用口"}, {"probability": {"variance": 0.004735, "average": 0.961532, "min": 0.754678}, "location": {"width": 349, "top": 1959, "height": 38, "left": 278}, "words": "服避孕药时应注意其浓度增高"}, {"probability": {"variance": 0.03202, "average": 0.8795, "min": 0.355599}, "location": {"width": 1001, "top": 2011, "height": 59, "left": 322}, "words": "考来拍(胆):本品与考来替泊合用,打伐他汀及其活栏代谢产物的血浆浓"}], "language": 3}